Compare Pfizer with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs SUN PHARMA - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER SUN PHARMA PFIZER/
SUN PHARMA
 
P/E (TTM) x 37.4 27.3 137.3% View Chart
P/BV x 6.3 2.8 229.6% View Chart
Dividend Yield % 0.5 0.6 93.2%  

Financials

 PFIZER   SUN PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-19
SUN PHARMA
Mar-19
PFIZER/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs3,840679 565.7%   
Low Rs2,080375 554.1%   
Sales per share (Unadj.) Rs455.0121.1 375.6%  
Earnings per share (Unadj.) Rs93.813.4 701.1%  
Cash flow per share (Unadj.) Rs109.420.7 528.8%  
Dividends per share (Unadj.) Rs22.502.75 818.2%  
Dividend yield (eoy) %0.80.5 145.7%  
Book value per share (Unadj.) Rs658.2172.6 381.4%  
Shares outstanding (eoy) m45.752,399.26 1.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.54.4 149.5%   
Avg P/E ratio x31.639.4 80.1%  
P/CF ratio (eoy) x27.125.5 106.2%  
Price / Book Value ratio x4.53.1 147.2%  
Dividend payout %24.020.6 116.7%   
Avg Mkt Cap Rs m135,4201,264,650 10.7%   
No. of employees `0002.617.5 15.0%   
Total wages/salary Rs m3,23859,671 5.4%   
Avg. sales/employee Rs Th7,911.416,608.1 47.6%   
Avg. wages/employee Rs Th1,230.93,409.6 36.1%   
Avg. net profit/employee Rs Th1,630.71,833.8 88.9%   
INCOME DATA
Net Sales Rs m20,815290,659 7.2%  
Other income Rs m1,67410,255 16.3%   
Total revenues Rs m22,489300,914 7.5%   
Gross profit Rs m5,71263,076 9.1%  
Depreciation Rs m71417,533 4.1%   
Interest Rs m735,553 1.3%   
Profit before tax Rs m6,59950,246 13.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-12,144 0.0%   
Tax Rs m2,3096,009 38.4%   
Profit after tax Rs m4,29132,093 13.4%  
Gross profit margin %27.421.7 126.5%  
Effective tax rate %35.012.0 292.5%   
Net profit margin %20.611.0 186.7%  
BALANCE SHEET DATA
Current assets Rs m27,167310,692 8.7%   
Current liabilities Rs m8,917173,396 5.1%   
Net working cap to sales %87.747.2 185.6%  
Current ratio x3.01.8 170.0%  
Inventory Days Days6899 68.5%  
Debtors Days Days30112 27.0%  
Net fixed assets Rs m8,862232,477 3.8%   
Share capital Rs m4582,399 19.1%   
"Free" reserves Rs m29,656411,691 7.2%   
Net worth Rs m30,113414,091 7.3%   
Long term debt Rs m2515,226 0.2%   
Total assets Rs m39,400646,938 6.1%  
Interest coverage x91.510.0 910.7%   
Debt to equity ratio x00 2.3%  
Sales to assets ratio x0.50.4 117.6%   
Return on assets %11.15.8 190.3%  
Return on equity %14.27.8 183.8%  
Return on capital %22.110.2 217.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m42866,025 0.6%   
Fx outflow Rs m78638,610 2.0%   
Net fx Rs m-35827,415 -1.3%   
CASH FLOW
From Operations Rs m97821,965 4.5%  
From Investments Rs m351-6,813 -5.2%  
From Financial Activity Rs m-1,099-27,305 4.0%  
Net Cashflow Rs m231-8,442 -2.7%  

Share Holding

Indian Promoters % 0.0 63.7 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 5.1 146.2%  
FIIs % 4.9 23.0 21.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 8.3 285.5%  
Shareholders   85,207 133,026 64.1%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   AJANTA PHARMA  GLENMARK PHARMA  AUROBINDO PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 429 Points Higher; Auto and IT Stocks Rally(Closing)

Indian share markets extended gains for the second consecutive day and ended on a strong note, tracking gains in Asian peers and Wall Street.

Related Views on News

PFIZER Share Price Up by 7%; BSE HEALTHCARE Index Up 0.3% (Market Updates)

Jul 2, 2020 | Updated on Jul 2, 2020

PFIZER share price is trading up by 7% and its current market price is Rs 4,245. The BSE HEALTHCARE is up by 0.3%. The top gainers in the BSE HEALTHCARE Index is PFIZER (up 6.8%). The top losers are BLISS GVS PHARMA (down 0.1%) and PIRAMAL ENTERPRISES (down 0.1%).

SUN PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 31.6% (Quarterly Result Update)

May 28, 2020 | Updated on May 28, 2020

For the quarter ended March 2020, SUN PHARMA has posted a net profit of Rs 5 bn (down 31.6% YoY). Sales on the other hand came in at Rs 82 bn (up 14.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

PFIZER Announces Quarterly Results (3QFY20); Net Profit Up 5.4% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, PFIZER has posted a net profit of Rs 1 bn (up 5.4% YoY). Sales on the other hand came in at Rs 5 bn (up 4.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 29.8% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, SUN PHARMA has posted a net profit of Rs 10 bn (down 29.8% YoY). Sales on the other hand came in at Rs 82 bn (up 5.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

This is How You Should Trade Intraday(Fast Profits Daily)

Jun 19, 2020

In this video, I'll show you how to trade the market intraday like a professional trader.

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

This Ratio Says Smallcaps Are Your Best Bet to Ride the Post Covid Market Rebound(Profit Hunter)

Jun 23, 2020

Here's why I believe that post Covid rebound in smallcaps will be much sharper than largecaps.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Jul 2, 2020 03:35 PM

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS